SCHEMBL10007983

SCHEMBL10007983

CC[C@@H](O)CCCCCCCCCCCO

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
PSMD14 O00487 2/20 0.42
PLA2G1B P04054 2/20 0.42
MMP2 P08253 2/20 0.42
ATG4B Q9Y4P1 2/20 0.42
HSP90AA1 P07900 1/20 0.42
RAD52 P43351 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
GPR84 Q9NQS5 5/20 0.40
FFAR4 Q5NUL3 1/20 0.39
FFAR1 O14842 1/20 0.39
PTPN1 P18031 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL555852 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6888416 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL897366 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL887706 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL554611 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL483813 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL12491170 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
1,6-Hexanediol SCHEMBL4564056 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL20680773 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL427921 1.00 LMNA (0.46) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11981952-B2 Methods of producing omega-hydroxylated fatty acid derivatives GENOMATICA, INC. (US) 2024-05-14 US disclosed
US-20240117324-A1 ACYL-ACP Reductase With Improved Properties AGAIN BIO APS (DK) 2024-04-11 US disclosed
US-20230167419-A1 Omega-Hydroxylase-Related Fusion Polypeptides With Improved Properties AGAIN BIO APS (DK) 2023-06-01 US disclosed
US-20220267813-A1 Microbial Production Of Fatty Diols GENOMATICA, INC. 2022-08-25 US disclosed
US-11421206-B2 Omega-hydroxylase-related fusion polypeptides with improved properties GENOMATICA, INC. (US) 2022-08-23 US disclosed
US-11359216-B2 Microbial production of fatty diols GENOMATICA, INC. (US) 2022-06-14 US disclosed
US-11339384-B2 Thioesterase variants having improved activity for the production of medium-chain fatty acid derivatives GENOMATICA, INC. (US) 2022-05-24 US disclosed
US-20220090028-A1 ACYL-ACP Reductase With Improved Properties GENOMATICA, INC. 2022-03-24 US disclosed
US-20210310033-A1 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS AGAIN BIO APS (DK) 2021-10-07 US disclosed
US-11130944-B2 Acyl-ACP reductase with improved properties GENOMATICA, INC. (US) 2021-09-28 US disclosed
US-20170029854-A1 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS REG Life Sciences, LLC (US) 2017-02-02 US disclosed
US-20160348080-A1 ACYL-ACP REDUCTASE WITH IMPROVED PROPERTIES GENOMATICA, INC. 2016-12-01 US disclosed
EP-3077526-A1 MICROBIAL PRODUCTION OF FATTY AMINES REG Life Sciences, LLC (US) 2016-10-12 EP disclosed
WO-2015157719-A9 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS REG Life Sciences, LLC (US) 2016-08-04 WO disclosed
US-20160002681-A1 ACP-MEDIATED PRODUCTION OF FATTY ACID DERIVATIVES REG Life Sciences, LLC (US) 2016-01-07 US disclosed
US-20150361454-A1 ACYL-ACP REDUCTASE WITH IMPROVED PROPERTIES REG Life Sciences, LLC (US) 2015-12-17 US disclosed
WO-2015157719-A1 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS REG Life Sciences, LLC (US) 2015-10-15 WO disclosed
WO-2015085271-A1 MICROBIAL PRODUCTION OF FATTY AMINES REG Life Sciences, LLC (US) 2015-06-11 WO disclosed
US-20150064782-A1 PRODUCTION OF FATTY ACID DERIVATIVES REG Life Sciences, LLC (US) 2015-03-05 US disclosed
US-20120172281-A1 DETERGENT COMPOSITIONS COMPRISING MICROBIALLY PRODUCED FATTY ALCOHOLS AND DERIVATIVES THEREOF THE PROCTER & GAMBLE COMPANY 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172281-A1 DETERGENT COMPOSITIONS COMPRISING MICROBIALLY PRODUCED FATTY ALCOHOLS AND DERIVATIVES THEREOF MGLL, DAGLA, ADH1C LMNA 2835/4885ALDH1A1 282/4885HSD17B10 245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.